Global and Japan Cancer Treatment Drugs Market Insights, Forecast to 2027

Global and Japan Cancer Treatment Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Cancer Treatment Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Treatment Drugs Market Size Growth Rate by Type
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Treatment Drugs Market Size Growth Rate by Application
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cancer Treatment Drugs Market Size, Estimates and Forecasts
2.1.1 Global Cancer Treatment Drugs Revenue 2016-2027
2.1.2 Global Cancer Treatment Drugs Sales 2016-2027
2.2 Global Cancer Treatment Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Cancer Treatment Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Cancer Treatment Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Cancer Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Cancer Treatment Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Cancer Treatment Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Cancer Treatment Drugs Revenue Forecast by Region (2022-2027)
3 Global Cancer Treatment Drugs Competitor Landscape by Players
3.1 Global Top Cancer Treatment Drugs Manufacturers by Sales
3.1.1 Global Cancer Treatment Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Cancer Treatment Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Cancer Treatment Drugs Manufacturers by Revenue
3.2.1 Key Cancer Treatment Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Cancer Treatment Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Cancer Treatment Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Cancer Treatment Drugs Revenue in 2020
3.2.6 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Treatment Drugs Price by Manufacturers
3.4 Global Cancer Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Cancer Treatment Drugs Market Size by Type (2016-2021)
4.1.1 Global Cancer Treatment Drugs Sales by Type (2016-2021)
4.1.2 Global Cancer Treatment Drugs Revenue by Type (2016-2021)
4.1.3 Cancer Treatment Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Cancer Treatment Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Cancer Treatment Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Cancer Treatment Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Cancer Treatment Drugs Market Size by Application (2016-2021)
5.1.1 Global Cancer Treatment Drugs Sales by Application (2016-2021)
5.1.2 Global Cancer Treatment Drugs Revenue by Application (2016-2021)
5.1.3 Cancer Treatment Drugs Price by Application (2016-2021)
5.2 Cancer Treatment Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Cancer Treatment Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Cancer Treatment Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Cancer Treatment Drugs Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Cancer Treatment Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Cancer Treatment Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Cancer Treatment Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Cancer Treatment Drugs Market Share in Global Market 2016-2027
6.2 Japan Cancer Treatment Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Cancer Treatment Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Cancer Treatment Drugs Players by Revenue (2016-2021)
6.3 Japan Cancer Treatment Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Cancer Treatment Drugs Price by Type (2016-2021)
6.4 Japan Cancer Treatment Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Cancer Treatment Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Cancer Treatment Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Cancer Treatment Drugs Price Forecast by Type (2022-2027)
6.5 Japan Cancer Treatment Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Cancer Treatment Drugs Price by Application (2016-2021)
6.6 Japan Cancer Treatment Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Cancer Treatment Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Cancer Treatment Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Cancer Treatment Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Cancer Treatment Drugs Market Size YoY Growth 2016-2027
7.2 North America Cancer Treatment Drugs Market Facts & Figures by Country
7.2.1 North America Cancer Treatment Drugs Sales by Country (2016-2021)
7.2.2 North America Cancer Treatment Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Cancer Treatment Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Cancer Treatment Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Cancer Treatment Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Cancer Treatment Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Cancer Treatment Drugs Market Size YoY Growth 2016-2027
9.2 Europe Cancer Treatment Drugs Market Facts & Figures by Country
9.2.1 Europe Cancer Treatment Drugs Sales by Country (2016-2021)
9.2.2 Europe Cancer Treatment Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Cancer Treatment Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Cancer Treatment Drugs Market Facts & Figures by Country
10.2.1 Latin America Cancer Treatment Drugs Sales by Country (2016-2021)
10.2.2 Latin America Cancer Treatment Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cancer Treatment Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Cancer Treatment Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Treatment Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Cancer Treatment Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Cancer Treatment Drugs Products Offered
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Cancer Treatment Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Corporation Information
12.3.2 Celgene Description and Business Overview
12.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Celgene Cancer Treatment Drugs Products Offered
12.3.5 Celgene Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Description and Business Overview
12.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Description and Business Overview
12.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amgen Cancer Treatment Drugs Products Offered
12.5.5 Amgen Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Johnson & Johnson Cancer Treatment Drugs Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Cancer Treatment Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 Takeda
12.8.1 Takeda Corporation Information
12.8.2 Takeda Description and Business Overview
12.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Takeda Cancer Treatment Drugs Products Offered
12.8.5 Takeda Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Description and Business Overview
12.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Cancer Treatment Drugs Products Offered
12.9.5 Eli Lilly Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Corporation Information
12.10.2 AstraZeneca Description and Business Overview
12.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 AstraZeneca Cancer Treatment Drugs Products Offered
12.10.5 AstraZeneca Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Cancer Treatment Drugs Products Offered
12.11.5 Roche Recent Development
12.12 Merck & Co.
12.12.1 Merck & Co. Corporation Information
12.12.2 Merck & Co. Description and Business Overview
12.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Merck & Co. Products Offered
12.12.5 Merck & Co. Recent Development
12.13 Sanofi
12.13.1 Sanofi Corporation Information
12.13.2 Sanofi Description and Business Overview
12.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sanofi Products Offered
12.13.5 Sanofi Recent Development
12.14 Bayer
12.14.1 Bayer Corporation Information
12.14.2 Bayer Description and Business Overview
12.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Bayer Products Offered
12.14.5 Bayer Recent Development
12.15 Biogen Idec
12.15.1 Biogen Idec Corporation Information
12.15.2 Biogen Idec Description and Business Overview
12.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Biogen Idec Products Offered
12.15.5 Biogen Idec Recent Development
12.16 Eisai
12.16.1 Eisai Corporation Information
12.16.2 Eisai Description and Business Overview
12.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Eisai Products Offered
12.16.5 Eisai Recent Development
12.17 Teva
12.17.1 Teva Corporation Information
12.17.2 Teva Description and Business Overview
12.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Teva Products Offered
12.17.5 Teva Recent Development
12.18 Otsuka
12.18.1 Otsuka Corporation Information
12.18.2 Otsuka Description and Business Overview
12.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Otsuka Products Offered
12.18.5 Otsuka Recent Development
12.19 Merck KGaA
12.19.1 Merck KGaA Corporation Information
12.19.2 Merck KGaA Description and Business Overview
12.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Merck KGaA Products Offered
12.19.5 Merck KGaA Recent Development
12.20 Ipsen
12.20.1 Ipsen Corporation Information
12.20.2 Ipsen Description and Business Overview
12.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Ipsen Products Offered
12.20.5 Ipsen Recent Development
12.21 AbbVie
12.21.1 AbbVie Corporation Information
12.21.2 AbbVie Description and Business Overview
12.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.21.4 AbbVie Products Offered
12.21.5 AbbVie Recent Development
12.22 Gilead Sciences
12.22.1 Gilead Sciences Corporation Information
12.22.2 Gilead Sciences Description and Business Overview
12.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Gilead Sciences Products Offered
12.22.5 Gilead Sciences Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Cancer Treatment Drugs Industry Trends
13.2 Cancer Treatment Drugs Market Drivers
13.3 Cancer Treatment Drugs Market Challenges
13.4 Cancer Treatment Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Treatment Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Cancer Treatment Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Chemotherapy
Table 3. Major Manufacturers of Targeted Therapy
Table 4. Major Manufacturers of Immunotherapy
Table 5. Major Manufacturers of Hormonal Therapy (Biologic Therapy)
Table 6. Major Manufacturers of Others
Table 7. Global Cancer Treatment Drugs Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 8. Global Cancer Treatment Drugs Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Cancer Treatment Drugs Sales by Regions (2016-2021) & (K Pcs)
Table 10. Global Cancer Treatment Drugs Sales Market Share by Regions (2016-2021)
Table 11. Global Cancer Treatment Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Cancer Treatment Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 13. Global Cancer Treatment Drugs Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Cancer Treatment Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Cancer Treatment Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Cancer Treatment Drugs Sales by Manufacturers (2016-2021) (K Pcs)
Table 17. Global Cancer Treatment Drugs Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Cancer Treatment Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 19. Cancer Treatment Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Cancer Treatment Drugs Revenue Share by Manufacturers (2016-2021)
Table 21. Global Cancer Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Treatment Drugs as of 2020)
Table 23. Key Manufacturers Cancer Treatment Drugs Price (2016-2021) (USD/Pcs)
Table 24. Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Cancer Treatment Drugs Product Type
Table 26. Date of International Manufacturers Enter into Cancer Treatment Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Treatment Drugs Sales by Type (2016-2021) (K Pcs)
Table 29. Global Cancer Treatment Drugs Sales Share by Type (2016-2021)
Table 30. Global Cancer Treatment Drugs Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Cancer Treatment Drugs Revenue Share by Type (2016-2021)
Table 32. Cancer Treatment Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 33. Global Cancer Treatment Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 34. Global Cancer Treatment Drugs Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Cancer Treatment Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Cancer Treatment Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Cancer Treatment Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 38. Global Cancer Treatment Drugs Sales by Application (2016-2021) (K Pcs)
Table 39. Global Cancer Treatment Drugs Sales Share by Application (2016-2021)
Table 40. Global Cancer Treatment Drugs Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Cancer Treatment Drugs Revenue Share by Application (2016-2021)
Table 42. Cancer Treatment Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 43. Global Cancer Treatment Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 44. Global Cancer Treatment Drugs Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Cancer Treatment Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Cancer Treatment Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Cancer Treatment Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 48. Japan Cancer Treatment Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 49. Japan Cancer Treatment Drugs Sales Share by Company (2016-2021)
Table 50. Japan Cancer Treatment Drugs Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Cancer Treatment Drugs Revenue Share by Company (2016-2021)
Table 52. Japan Cancer Treatment Drugs Sales (K Pcs) by Type (2016-2021)
Table 53. Japan Cancer Treatment Drugs Sales Share by Type (2016-2021)
Table 54. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Cancer Treatment Drugs Price (USD/Pcs) by Type (2016-2021)
Table 56. Japan Cancer Treatment Drugs Sales (K Pcs) by Type (2022-2027)
Table 57. Japan Cancer Treatment Drugs Sales Share by Type (2022-2027)
Table 58. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Cancer Treatment Drugs Revenue Share by Type (2022-2027)
Table 60. Japan Cancer Treatment Drugs Price (USD/Pcs) by Type (2022-2027)
Table 61. Japan Cancer Treatment Drugs Sales (K Pcs) by Application (2016-2021)
Table 62. Japan Cancer Treatment Drugs Sales Share by Application (2016-2021)
Table 63. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Cancer Treatment Drugs Price (USD/Pcs) by Application (2016-2021)
Table 65. Japan Cancer Treatment Drugs Sales (K Pcs) by Application (2022-2027)
Table 66. Japan Cancer Treatment Drugs Sales Share by Application (2022-2027)
Table 67. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Cancer Treatment Drugs Revenue Share by Application (2022-2027)
Table 69. Japan Cancer Treatment Drugs Price (USD/Pcs) by Application (2022-2027)
Table 70. North America Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 71. North America Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 72. North America Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Cancer Treatment Drugs Sales by Region (2016-2021) & (K Pcs)
Table 75. Asia Pacific Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Cancer Treatment Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Cancer Treatment Drugs Revenue Market Share by Region (2016-2021)
Table 78. Europe Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 79. Europe Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 80. Europe Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 82. Latin America Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 83. Latin America Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 87. Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 93. Roche Cancer Treatment Drugs Product
Table 94. Roche Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. Celgene Corporation Information
Table 101. Celgene Description and Business Overview
Table 102. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 103. Celgene Product
Table 104. Celgene Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 108. Bristol-Myers Squibb Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Amgen Corporation Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Amgen Product
Table 114. Amgen Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Product
Table 119. Johnson & Johnson Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Pfizer Product
Table 124. Pfizer Recent Development
Table 125. Takeda Corporation Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Takeda Product
Table 129. Takeda Recent Development
Table 130. Eli Lilly Corporation Information
Table 131. Eli Lilly Description and Business Overview
Table 132. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Eli Lilly Product
Table 134. Eli Lilly Recent Development
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. AstraZeneca Product
Table 139. AstraZeneca Recent Development
Table 140. Astellas Corporation Information
Table 141. Astellas Description and Business Overview
Table 142. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Astellas Product
Table 144. Astellas Recent Development
Table 145. Merck & Co. Corporation Information
Table 146. Merck & Co. Description and Business Overview
Table 147. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 148. Merck & Co. Product
Table 149. Merck & Co. Recent Development
Table 150. Sanofi Corporation Information
Table 151. Sanofi Description and Business Overview
Table 152. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 153. Sanofi Product
Table 154. Sanofi Recent Development
Table 155. Bayer Corporation Information
Table 156. Bayer Description and Business Overview
Table 157. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Bayer Product
Table 159. Bayer Recent Development
Table 160. Biogen Idec Corporation Information
Table 161. Biogen Idec Description and Business Overview
Table 162. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Biogen Idec Product
Table 164. Biogen Idec Recent Development
Table 165. Eisai Corporation Information
Table 166. Eisai Description and Business Overview
Table 167. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Eisai Product
Table 169. Eisai Recent Development
Table 170. Teva Corporation Information
Table 171. Teva Description and Business Overview
Table 172. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Teva Product
Table 174. Teva Recent Development
Table 175. Otsuka Corporation Information
Table 176. Otsuka Description and Business Overview
Table 177. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Otsuka Product
Table 179. Otsuka Recent Development
Table 180. Merck KGaA Corporation Information
Table 181. Merck KGaA Description and Business Overview
Table 182. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Merck KGaA Product
Table 184. Merck KGaA Recent Development
Table 185. Ipsen Corporation Information
Table 186. Ipsen Description and Business Overview
Table 187. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Ipsen Product
Table 189. Ipsen Recent Development
Table 190. AbbVie Corporation Information
Table 191. AbbVie Description and Business Overview
Table 192. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. AbbVie Product
Table 194. AbbVie Recent Development
Table 195. Gilead Sciences Corporation Information
Table 196. Gilead Sciences Description and Business Overview
Table 197. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Gilead Sciences Product
Table 199. Gilead Sciences Recent Development
Table 200. Cancer Treatment Drugs Market Trends
Table 201. Cancer Treatment Drugs Market Drivers
Table 202. Cancer Treatment Drugs Market Challenges
Table 203. Cancer Treatment Drugs Market Restraints
Table 204. Cancer Treatment Drugs Customers List
Table 205. Cancer Treatment Drugs Distributors List
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Treatment Drugs Product Picture
Figure 2. Global Cancer Treatment Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Chemotherapy Product Picture
Figure 4. Targeted Therapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cancer Treatment Drugs Sales Market Share by Application in 2020 & 2027
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. Gastrointestinal Cancer
Figure 12. Prostate Cancer
Figure 13. Respiratory or Lung Cancer
Figure 14. Others
Figure 15. Cancer Treatment Drugs Report Years Considered
Figure 16. Global Cancer Treatment Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Cancer Treatment Drugs Market Size 2016-2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs